DIAGNOS (CVE:ADK) Sets New 1-Year High – Here’s Why

DIAGNOS Inc. (CVE:ADK)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as C$0.41 and last traded at C$0.40, with a volume of 1041344 shares changing hands. The stock had previously closed at C$0.39.

DIAGNOS Stock Performance

The company has a debt-to-equity ratio of 204.05, a quick ratio of 0.68 and a current ratio of 1.49. The firm has a market cap of C$47.56 million, a P/E ratio of -9.88 and a beta of -0.14. The firm’s fifty day moving average price is C$0.25 and its 200 day moving average price is C$0.26.

Insider Transactions at DIAGNOS

In other DIAGNOS news, Director Robert Dunn bought 200,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The shares were purchased at an average cost of C$0.30 per share, for a total transaction of C$60,000.00. Following the purchase, the director directly owned 2,117,778 shares in the company, valued at C$635,333.40. This represents a 10.43% increase in their ownership of the stock. Insiders have acquired 328,571 shares of company stock valued at $96,000 over the last 90 days. 16.81% of the stock is currently owned by insiders.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.